Molecular Devices Announces Webcast of Presentation at Thomas Weisel Partners Growth Forum 7.0
June 08 2005 - 4:24PM
PR Newswire (US)
Molecular Devices Announces Webcast of Presentation at Thomas
Weisel Partners Growth Forum 7.0 SUNNYVALE, Calif., June 8
/PRNewswire-FirstCall/ -- Molecular Devices Corporation
(NASDAQ:MDCC), a leader in innovative solutions for drug discovery
and life sciences research, today announced that Joseph D. Keegan,
Ph.D., CEO and President, will present at the Thomas Weisel
Partners Growth Forum 7.0 on Tuesday, June 14, 2005 at 9:45 a.m.
(PDT) at the Four Seasons Hotel in San Francisco. Molecular
Devices' audio presentation will be webcast live, and can be
accessed at:
http://www.veracast.com/webcasts/twp/GF2005/71204478.cfm or on the
investor page at the Company's website
http://www.moleculardevices.com/. The presentation will be archived
on the Company's website for 5 days. Molecular Devices Corporation
is a leading supplier of high-performance bioanalytical measurement
systems that accelerate and improve drug discovery and other life
sciences research. The Company's systems and consumables enable
pharmaceutical and biotechnology companies to leverage advances in
genomics, proteomics and parallel chemistry to facilitate the
high-throughput and cost-effective identification and evaluation of
drug candidates. The Company's solutions are based on its advanced
core technologies that integrate its expertise in engineering,
molecular and cell biology and chemistry. Molecular Devices enables
its customers to improve research productivity and effectiveness,
which ultimately accelerates the complex process of discovering and
developing new drugs. DATASOURCE: Molecular Devices Corporation
CONTACT: Tim Harkness of Molecular Devices Corporation,
+1-408-747-3533 Web site: http://www.moleculardevices.com/
Copyright
Molecular Devices (NASDAQ:MDCC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Molecular Devices (NASDAQ:MDCC)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Molecular Devices (MM) (NASDAQ): 0 recent articles
More Molecular Devices (MM) News Articles